# Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis

> **NCT03480191** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 112 (actual)

## Conditions studied

- Pneumococcal Meningitis

## Interventions

- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT03480191
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-07
- **Primary completion:** 2024-05-11
- **Final completion:** 2024-08-21
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480191, "Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03480191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*